• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthNobel Prizes

Nobel Prize in medicine awarded to 2 U.S. scientists who discovered microRNA, which regulates gene activity

By
Pia Ohlin
Pia Ohlin
and
AFP
AFP
Down Arrow Button Icon
By
Pia Ohlin
Pia Ohlin
and
AFP
AFP
Down Arrow Button Icon
October 7, 2024, 7:01 AM ET
Nobel Committee announces the winners of the 2024 Nobel Prize in Physiology or Medicine during a press conference in Stockholm, on Oct. 7, 2024. The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for their microRNA discovery and gene regulation studies.
Nobel Committee announces the winners of the 2024 Nobel Prize in Physiology or Medicine during a press conference in Stockholm, on Oct. 7, 2024. The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for their microRNA discovery and gene regulation studies.Atila Altuntas—Anadolu via Getty Images

US scientists Victor Ambros and Gary Ruvkun won the Nobel Prize in Medicine on Monday for their discovery of microRNA and its role in how genes are regulated.

Recommended Video

Understanding the regulation of gene activity has been an important goal for decades, the Nobel jury said.

If gene regulation goes awry, it can lead to serious diseases such as cancer, diabetes, or autoimmunity.

“Their groundbreaking discovery revealed a completely new principle of gene regulation that turned out to be essential for multicellular organisms, including humans,” the jury said.

Collaborating but working separately, the pair conducted research on a 1 millimeter roundworm, C. Elegans, to determine why cell mutations occurred and when.

They discovered microRNA, a new class of tiny RNA molecules that play a crucial role in gene regulation, which in turn allows each cell to select only relevant instructions.

Their findings were published in two articles in 1993.

“The seminal discovery of microRNA has introduced a new and unexpected mechanism of gene regulation,” Thomas Perlmann, secretary general of the Nobel Assembly, told reporters.

“MicroRNAs are important for our understanding of embryological development, normal cell physiology and diseases such as cancer,” he said.

Ambros, 70, is a professor at the University of Massachusetts medical school while Ruvkun, 72, is a professor at Harvard Medical School.

The pair will receive their Nobel prize, consisting of a diploma, a gold medal and a $1 million cheque, from King Carl XVI Gustaf in Stockholm on December 10, the anniversary of the 1896 death of scientist Alfred Nobel who created the prizes in his last will and testament.

Last year, the medicine prize went to Katalin Kariko and Drew Weissman for work on messenger RNA (mRNA) technology that paved the way for Covid-19 vaccines.

The Nobel season continues this week with the announcement of the winners of the physics prize on Tuesday and the chemistry prize on Wednesday.

They will be followed by the much-anticipated prizes for literature on Thursday and peace on Friday.

The economics prize winds things up on Monday, October 14.

Awarded since 1901, the Nobel Prizes honour those who have, in the words of Alfred Nobel, “conferred the greatest benefit on humankind”, highlighting encouraging advances as the world currently witnesses devastating wars in the Middle East and Ukraine and a climate on the brink of collapse.

Who deserves Peace Prize?

For Tuesday’s Nobel Prize in Physics, Swedish public radio SR’s science experts suggested the honour could go to Swiss physicist Christoph Gerber, a pioneer in the development of the atomic force microscope.

“This is a microscope that gives 3D images on such an incredibly small scale that they sometimes are even atomic resolution,” said SR science reporter Camilla Widebeck.

The tool has become indispensable in nanotechnology and nano research, she added.

The Clarivate analytics group also highlighted David Deutsch and Peter Shor for their work on quantum algorithms and quantum computing.

Speculation is also rife for the literature prize, to be announced on Thursday and perhaps the most highly anticipated Nobel after the peace prize.

Several pundits believe Chinese author Can Xue will be the Swedish Academy’s choice this year — and she has the lowest odds on several betting sites.

An avant-garde fiction writer often likened to Kafka, her experimental style flips between utopia and dystopia and transforms the mundane into the surreal.

“I think it will be a woman from a language zone outside Europe,” Bjorn Wiman, culture editor at Sweden’s newspaper of record, Dagens Nyheter, told AFP.

Others suggest it could go to Australian novelist Gerald Murnane, Britain’s Salman Rushdie or Kenya’s Ngugi wa Thiong’o.

The climax of the week comes Friday when the Nobel Peace Prize laureate is announced, but experts say predictions are harder than ever this year due to the growing number of crises in the world.

The UN agency for Palestinian refugees UNRWA, the International Court of Justice and Afghan women’s rights activist Mahbouba Seraj have been mentioned as possibilities.

Given the existential risks to humanity posed by weapons systems that can operate autonomously without human control, several Nobel-watchers have also cited the Campaign to Stop Killer Robots as a potential laureate.

Join us at the Coins2Day Workplace Innovation Summit May 19–20, 2026, in Atlanta. The next era of workplace innovation is here—and the old playbook is being rewritten. At this exclusive, high-energy event, the world’s most innovative leaders will convene to explore how AI, humanity, and strategy converge to redefine, again, the future of work. Register now.
About the Authors
By Pia Ohlin
See full bioRight Arrow Button Icon
By AFP
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Coins2Day Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
North America
'I meant what I said in Davos': Carney says he really is planning a Canada split with the U.S. along with 12 new trade deals
By Rob Gillies and The Associated PressJanuary 28, 2026
18 hours ago
placeholder alt text
C-Suite
Coins2Day 500 CEOs are no longer giving employees an A for effort. Now they want proof of impact
By Claire ZillmanJanuary 28, 2026
1 day ago
placeholder alt text
Real Estate
Ryan Serhant thinks the American Dream was just a 'slogan created by banks,' but it was really about FDR, the Great Depression, and an economic crisis
By Sydney Lake and Nick LichtenbergJanuary 26, 2026
3 days ago
placeholder alt text
Commentary
Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
By Daniel BunnJanuary 26, 2026
3 days ago
placeholder alt text
Personal Finance
Current price of silver as of Tuesday, January 27, 2026
By Joseph HostetlerJanuary 27, 2026
2 days ago
placeholder alt text
Success
As AI wipes out desk jobs, Citigroup CEO Jane Fraser says the company is training 175,000 employees to ‘reinvent themselves’ before their roles change forever
By Emma BurleighJanuary 27, 2026
2 days ago

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Healthoutdoor and sporting goods
The 4 Best Cold Plunge Tubs of 2026: Reviewed by Testers and Experts
By Christina SnyderJanuary 28, 2026
12 hours ago
succession
SuccessFamily
How not to say that thing you’ll regret forever: 3 rules for family conversations about money 
By Glenn KurlanderJanuary 28, 2026
19 hours ago
reem
Commentaryhunger
How to fight child hunger in a time of foreign aid cuts
By Reem Alabali Radovan, Rajiv J. Shah and Mads Krogsgaard ThomsenJanuary 28, 2026
23 hours ago
People walk outside of a WeWork office building in London.
Future of WorkOffice Culture
Amazon and JPMorgan led the Coins2Day 500 in returning to the office 5 days a week. Now they’re leading a coworking comeback
By Jacqueline MunisJanuary 27, 2026
1 day ago
Healthbeauty
5 Best Red Light Therapy Panels of 2026: Personally Tested
By Christina SnyderJanuary 27, 2026
1 day ago
Graphic reads: Coins2Day Titans and Disruptors of Industry with Albert Bourla, CEO of Pfizer, Hosted by Alyson Shontell (both pictured).
C-SuiteCoins2Day 500: Titans and Disruptors of Industry
Pfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By Coins2Day EditorsJanuary 27, 2026
2 days ago